AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12067012 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 75 mg
Number of subjects: 40
Study 12067012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10592854 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic norgestimate/ethinyl estradiol (Ortho Tri‐Cyclen)
Number of subjects: 500
Study 10592854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 8712120 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 480
Study 8712120 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 480
Study 1759004 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol aerosol 400 micrograms before and 200 micrograms 2-hourly after challenge
Number of subjects: 9
Study 1759004 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral terfenadine 120 mg 2 h before and 10 h after challenge
Number of subjects: 9
Study 1759004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 1759004 — intervention group
Group type: COMPARATOR
Intervention: No medication or antigen challenge
Number of subjects: 9
Study 7137075 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% lactose
Number of subjects: 8
Study 7137075 — intervention group
Group type: COMPARATOR
Intervention: 50% lactose: 50% glucose polymer (lactose + glucose polymer)
Number of subjects: 8
Study 30683533 — intervention group
Group type: EXPERIMENTAL
Intervention: XEN® Gel Stent as a stand-alone procedure
Number of subjects: 777
Study 30683533 — intervention group
Group type: COMPARATOR
Intervention: XEN® Gel Stent in combined surgery
Number of subjects: 777
Study 30683533 — intervention group
Group type: EXPERIMENTAL
Intervention: XEN® Gel Stent (both procedures)
Number of subjects: 777
Study 28374714 — intervention group
Group type: EXPERIMENTAL
Intervention: Collost (medical device) in addition to standard therapy
Number of subjects: 71
Study 28374714 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 71
Study 26400520 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-iso-PGF2α
Number of subjects: 40
Study 26400520 — intervention group
Group type: EXPERIMENTAL
Intervention: Gpx
Number of subjects: 40
Study 26400520 — intervention group
Group type: EXPERIMENTAL
Intervention: SOD
Number of subjects: 40
Study 26400520 — intervention group
Group type: EXPERIMENTAL
Intervention: TBA
Number of subjects: 40
Study 23705925 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet + oral vitamin D (n = 33)
Number of subjects: 66
Study 23705925 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin D alone (control group, n = 33)
Number of subjects: 66
Study 21372283 — intervention group
Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in whites
Number of subjects: 1460
Study 21372283 — intervention group
Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in blacks
Number of subjects: 1460
Study 21372283 — intervention group
Group type: EXPERIMENTAL
Intervention: 9p21 haplotype comprising the risk allele for SNPs in Hispanics
Number of subjects: 1460
Study 21372283 — intervention group
Group type: EXPERIMENTAL
Intervention: Less commonly reported linkage disequilibrium block in whites
Number of subjects: 1460
Study 21372283 — intervention group
Group type: EXPERIMENTAL
Intervention: Less commonly reported linkage disequilibrium block in blacks
Number of subjects: 1460
Study 19804632 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program provided by trained psychologists and social workers, including counselling on work resumption and family support.
Number of subjects: 161
Study 19804632 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group) with access to welfare benefits.
Number of subjects: 161
Study 17276668 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloid preload
Number of subjects: 55
Study 17276668 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid preload
Number of subjects: 55
Study 15180765 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 250
Study 15180765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg
Number of subjects: 250
Study 15180765 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 12213858 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 58
Study 12213858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-stage neuroborreliosis
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage II features
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute meningomyelitis or meningomyeloradiculitis
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Meningoencephalitis or meningenocephaloradiculitis
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic course (stage III)
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrovascular neuroborreliosis
Number of subjects: 330
Study 9617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of other organs
Number of subjects: 330
Study 8571717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal polyglactin mesh
Number of subjects: 112
Study 8571717 — intervention group
Group type: COMPARATOR
Intervention: No intraperitoneal polyglactin mesh (control)
Number of subjects: 112
Study 2488104 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR) 100 mg
Number of subjects: 10
Study 2488104 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release metoprolol (CR) 200 mg
Number of subjects: 10
Study 2488104 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol Durules 200 mg
Number of subjects: 10
Study 2488104 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol plain tablet 100 mg
Number of subjects: 10
Study 2488104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 13418 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH administered to 6 patients with endogenous depressions
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: TRH 1000 mug for 10 days
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: MIF-1 60 mg per day for 6 days
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: MIF-1 150 mg per day
Number of subjects: 46
Study 13418 — intervention group
Group type: EXPERIMENTAL
Intervention: MIF-1 75 mg per day
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: MIF-1 750 mg per day
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 13418 — intervention group
Group type: EXPERIMENTAL
Intervention: LHRH 700 mug or saline once daily for 3 consecutive days per week
Number of subjects: 46
Study 13418 — intervention group
Group type: COMPARATOR
Intervention: Higher doses of LHRH in a single-blinded study
Number of subjects: 46
Study 31647470 — intervention group
Group type: EXPERIMENTAL
Intervention: 23vPPV vaccine
Number of subjects: 4725
Study 31647470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 4725
Study 29102353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (12 hospitals)
Number of subjects: 25
Study 29102353 — intervention group
Group type: COMPARATOR
Intervention: Control group (13 hospitals)
Number of subjects: 25
Study 29102353 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention effect
Number of subjects: 25
Study 26209121 — intervention group
Group type: EXPERIMENTAL
Intervention: Seizure First Aid Training intervention
Number of subjects: 80
Study 26209121 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 80
Study 23936304 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT guided treatment
Number of subjects: 337
Study 23936304 — intervention group
Group type: COMPARATOR
Intervention: Standard care clinical guidelines
Number of subjects: 337
Study 23672753 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted gastrectomy (LAG)
Number of subjects: 30
Study 23672753 — intervention group
Group type: COMPARATOR
Intervention: Conventional open gastrectomy (OG)
Number of subjects: 30
Study 19855285 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent therapy (IT)
Number of subjects: 391
Study 19855285 — intervention group
Group type: COMPARATOR
Intervention: Continuous therapy (CT)
Number of subjects: 391
Study 19855285 — intervention group
Group type: EXPERIMENTAL
Intervention: History of thrombocytopenia
Number of subjects: 391
Study 19855285 — intervention group
Group type: EXPERIMENTAL
Intervention: Low baseline platelet count
Number of subjects: 391
Study 19855285 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes from baseline in platelet counts
Number of subjects: 391
Study 16899100 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector ‐system with polishing (VP)
Number of subjects: 40
Study 16899100 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector ‐system with abrasive fluid (VA)
Number of subjects: 40
Study 16899100 — intervention group
Group type: COMPARATOR
Intervention: Conventional ultrasonic system (U)
Number of subjects: 40
Study 16899100 — intervention group
Group type: COMPARATOR
Intervention: Hand instruments (H)
Number of subjects: 40
Study 14763994 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum total testosterone levels in AD patients
Number of subjects: 30
Study 14763994 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum free testosterone levels in AD patients
Number of subjects: 30
Study 14763994 — intervention group
Group type: EXPERIMENTAL
Intervention: Free androgen index (FAI) in AD patients
Number of subjects: 30
Study 14763994 — intervention group
Group type: EXPERIMENTAL
Intervention: SHBG levels in AD patients
Number of subjects: 30
Study 14763994 — intervention group
Group type: COMPARATOR
Intervention: FAI in cognitively normal controls
Number of subjects: 30
Study 11280679 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (500 microg Se daily for 5 days)
Number of subjects: 31
Study 11280679 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 31
Study 9042045 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric completers
Number of subjects: 362
Study 7943386 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilt maneuver
Number of subjects: 0
Study 7943386 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing with constant heart rate
Number of subjects: 0
Study 3350203 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg aspirin daily
Number of subjects: 18
Study 3350203 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg dipyridamole three times daily
Number of subjects: 18
Study 3350203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of aspirin and dipyridamole
Number of subjects: 18
Study 31822377 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention for adolescent headache (SMI-AH, n = 13)
Number of subjects: 30
Study 31822377 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (n = 17)
Number of subjects: 30
Study 31822377 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management intervention for adolescent headache (SMI-AH)
Number of subjects: 30
Study 30767637 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanically-enriched topical salve (BES)
Number of subjects: 16
Study 30767637 — intervention group
Group type: COMPARATOR
Intervention: Base salve (BS)
Number of subjects: 16
Study 28225483 — intervention group
Group type: EXPERIMENTAL
Intervention: tHcy quartiles (Q2, Q3, Q4)
Number of subjects: 20424
Study 28225483 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR genotype (CC/CT)
Number of subjects: 20424
Study 25735707 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 90
Study 25735707 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 90
Study 25735707 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 90
Study 23086750 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorambucil and fludarabine with cyclophosphamide
Number of subjects: 494
Study 23086750 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil and fludarabine without cyclophosphamide
Number of subjects: 494
Study 21575959 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tadalafil 20 mg plus low dose intracavernous injection of vasoactive agents (15 mg papaverine plus 20 mg tadalafil)
Number of subjects: 56
Study 21575959 — intervention group
Group type: COMPARATOR
Intervention: Oral tadalafil 20 mg
Number of subjects: 56
Study 21575959 — intervention group
Group type: COMPARATOR
Intervention: Intracavernous injection mode (30 to 60 mg papaverine)
Number of subjects: 56
Study 21575959 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference
Number of subjects: 56
Study 20015432 — intervention group
Group type: EXPERIMENTAL
Intervention: Kneading and dispersing manipulation
Number of subjects: 198
Study 20015432 — intervention group
Group type: COMPARATOR
Intervention: Cefradine (oral administration)
Number of subjects: 198
Study 16413010 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (mean daily dose 3.11±1.62 mg)
Number of subjects: 239
Study 16413010 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐65 variant carriers
Number of subjects: 239
Study 16413010 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (Caucasians and African‐Americans)
Number of subjects: 239
Study 14652518 — intervention group
Group type: EXPERIMENTAL
Intervention: CONFOR‐Med mattress/cushion combination
Number of subjects: 1168
Study 14652518 — intervention group
Group type: COMPARATOR
Intervention: Standard mattress/cushion combination
Number of subjects: 1168
Study 11126272 — intervention group
Group type: EXPERIMENTAL
Intervention: iloprost infusion (1 ng/kg per minute) for 24 h
Number of subjects: 20
Study 11126272 — intervention group
Group type: COMPARATOR
Intervention: Control group not mentioned
Number of subjects: 20
Study 9236309 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy
Number of subjects: 189
Study 9236309 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy (first 12 weeks)
Number of subjects: 189
Study 9236309 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy (past 12 weeks)
Number of subjects: 189
Study 9236309 — intervention group
Group type: COMPARATOR
Intervention: Non-pregnant women
Number of subjects: 189
Study 9236309 — intervention group
Group type: EXPERIMENTAL
Intervention: Current pregnancy
Number of subjects: 189
Study 1615190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline
Number of subjects: 18
Study 1615190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6393181 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis and cognitive coping skills
Number of subjects: 61
Study 6393181 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation and cognitive coping skills
Number of subjects: 61
Study 6393181 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 61
Study 30944249 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet, primarily unsaturated
Number of subjects: 9
Study 30944249 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, high-carbohydrate diet
Number of subjects: 9
Study 29884657 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized, remote clinical pharmacy service for 12 months
Number of subjects: 302
Study 29884657 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302
Study 29884657 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized, remote clinical pharmacy service
Number of subjects: 302
Study 26073190 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast
Number of subjects: 20
Study 26073190 — intervention group
Group type: COMPARATOR
Intervention: Fasting (no breakfast)
Number of subjects: 20
Study 24939352 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual online learning
Number of subjects: 15
Study 24939352 — intervention group
Group type: EXPERIMENTAL
Intervention: Group online learning
Number of subjects: 15
Study 24939352 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 15
Study 22997781 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 64
Study 22997781 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 64
Study 19136144 — intervention group
Group type: COMPARATOR
Intervention: Long-acting opioid analgesics
Number of subjects: 10
Study 18620498 — intervention group
Group type: EXPERIMENTAL
Intervention: Phyllanthus niruri
Number of subjects: 0
Study 18620498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolichos biflorus
Number of subjects: 0
Study 18620498 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthosiphon grandiflorus
Number of subjects: 0
Study 18620498 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish stone
Number of subjects: 0
Study 11693062 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha as maintenance treatment
Number of subjects: 167
Study 11693062 — intervention group
Group type: COMPARATOR
Intervention: Cyclically alternating interferon alpha and dexamethasone treatment
Number of subjects: 167
Study 9204089 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% gel
Number of subjects: 591
Study 9204089 — intervention group
Group type: COMPARATOR
Intervention: Tretinoin 0.025% gel
Number of subjects: 591
Study 8434322 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL of standard-dose chymopapain (4,000 units)
Number of subjects: 118
Study 8434322 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mL of low-dose chymopapain (2,000 units)
Number of subjects: 118
Study 3304172 — intervention group
Group type: EXPERIMENTAL
Intervention: Creon
Number of subjects: 0
Study 3304172 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancrease
Number of subjects: 0
Study 3304172 — intervention group
Group type: COMPARATOR
Intervention: Pancrex V Forte
Number of subjects: 0
Study 3304172 — intervention group
Group type: COMPARATOR
Intervention: Pancreatin Merck
Number of subjects: 0
Study 29485322 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 8844
Study 29485322 — intervention group
Group type: EXPERIMENTAL
Intervention: CT Colonography
Number of subjects: 8844
Study 28704146 — intervention group
Group type: EXPERIMENTAL
Intervention: Legacy Intervention (LI)
Number of subjects: 80
Study 28704146 — intervention group
Group type: COMPARATOR
Intervention: Partial Hospital Program only (PHP-only)
Number of subjects: 80
Study 26817117 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment of NASH (Ursodeoxycholic acid 15 mg/kg once a day, Atorvastatin 20 mg at night, Vitamin E 800 IU/day for 12 months)
Number of subjects: 51
Study 26817117 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/day in addition to standard treatment for 12 months
Number of subjects: 51
Study 23021631 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable gas analysis system carried in a chest harness (PT)
Number of subjects: 8
Study 23021631 — intervention group
Group type: COMPARATOR
Intervention: Control trial with the system externally supported (CT)
Number of subjects: 8
Study 21248759 — intervention group
Group type: EXPERIMENTAL
Intervention: ELF‐EMF (1μT, 6- and 8 Hz, peak electric field 10 Vm(‐1), 10-15 min sessions, 2 sessions per week for 4 weeks)
Number of subjects: 20
Study 21248759 — intervention group
Group type: COMPARATOR
Intervention: Sham control (EMF-generating apparatus not active)
Number of subjects: 20
Study 18276852 — intervention group
Group type: EXPERIMENTAL
Intervention: NK1R antagonist (LY686017)
Number of subjects: 50
Study 18276852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) > 1.0 mg/dl
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Immature/total neutrophil ratio (I/T) > 0.2
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotension
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-for-gestational-age (SGA) status
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus-specific PCR
Number of subjects: 111
Study 16982493 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 111
Study 12963199 — intervention group
Group type: EXPERIMENTAL
Intervention: OPCAB procedure (group 2)
Number of subjects: 176
Study 12963199 — intervention group
Group type: COMPARATOR
Intervention: Coronary surgery with cardiopulmonary bypass (CPB) (group 1)
Number of subjects: 176
Study 11088095 — intervention group
Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol with 0.5 mg of norethindrone acetate
Number of subjects: 270
Study 11088095 — intervention group
Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol with 0.25 mg of norethindrone acetate
Number of subjects: 270
Study 11088095 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of 17‐beta estradiol
Number of subjects: 270
Study 11088095 — intervention group
Group type: EXPERIMENTAL
Intervention: 17‐beta estradiol
Number of subjects: 270
Study 11088095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 8956574 — intervention group
Group type: EXPERIMENTAL
Intervention: HASTE MR cholangiography
Number of subjects: 23
Study 8956574 — intervention group
Group type: COMPARATOR
Intervention: Sonography
Number of subjects: 23
Study 8956574 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiography
Number of subjects: 23
Study 1541032 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption
Number of subjects: 0
Study 1541032 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinking and binge drinking
Number of subjects: 0
Study 1541032 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0